Federal Regulators Launch Efforts to Cut Use of Antipsychotics in Nursing Homes

Federal regulators announced a multiyear initiative this week to reduce the inappropriate use of antipsychotic drugs on nursing home residents. According to the Boston Globe, nearly 40 percent of residents with dementia were receiving the powerful sedatives though they did not have a condition that would warrant it.

The US Centers for Medicare & Medicaid Services (CMS) said hopes to reduce the use of antipsychotic drugs in nursing home residents by 15 percent by the end of 201.  Treating dementia with antipsychotics is considered an "off-label" use of the drugs, which are approved to treat schizophrenia and bipolar disorder. CMS says they hope to encourage care providers to offer alternative solutions to dementia and combativeness in nursing homes. For more, read the story.



Robert W. Carter, Jr. is a Virginia attorney whose law practice is dedicated to protecting the rights of the victims of nursing home and assisted living neglect and abuse in Richmond, Roanoke, Norfolk, Lynchburg, Danville, Charlottesville, and across Virginia.


























No comments (Add your own)

Add a New Comment


code
 

Comment Guidelines: No HTML is allowed. Off-topic or inappropriate comments will be edited or deleted. Thanks.